These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22165615)

  • 1. [Botulinum toxin--the all-rounder in medicine].
    Schröder AS; Fietzek UM; Pavicic T; Stehr M; Baumann AC; Ruzicka T; Heinen F
    MMW Fortschr Med; 2011 Jan; 153(4):33-9; quiz 40. PubMed ID: 22165615
    [No Abstract]   [Full Text] [Related]  

  • 2. Dysport (botulinum toxin type A) in routine therapeutic usage: a telephone needs assessment survey of European physicians to evaluate current awareness and adherence to product labeling changes.
    Hubble J; Schwab J; Hubert C; Abbott CC
    Clin Neuropharmacol; 2013; 36(4):122-7. PubMed ID: 23783005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Safety and Dosing of OnabotulinumtoxinA: A Prospective, Observational Study.
    Wein T; Jog M; Bhogal M; Dhani S; Miller R; Ismail F; Beauchamp R; Trentin G
    Can J Neurol Sci; 2019 Nov; 46(6):742-752. PubMed ID: 31256770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications with the use of botulinum toxin.
    Klein AW
    Dermatol Clin; 2004 Apr; 22(2):197-205, vii. PubMed ID: 15222580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Botulinum toxin A in dermatology].
    Heckmann M; Ceballos-Baumann A; Schaller M; Plewig G
    Hautarzt; 1998 Feb; 49(2):87-90. PubMed ID: 9551328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type B (Myobloc).
    Baumann L; Black L
    Dermatol Surg; 2003 May; 29(5):496-500; discussion 500. PubMed ID: 12752517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes.
    Glogau RG
    Clin J Pain; 2002; 18(6 Suppl):S191-7. PubMed ID: 12569968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World, Long-Term Quality of Life Following Therapeutic OnabotulinumtoxinA Treatment.
    Jog M; Wein T; Bhogal M; Dhani S; Miller R; Ismail F; Beauchamp R; Trentin G
    Can J Neurol Sci; 2016 Sep; 43(5):687-96. PubMed ID: 27430524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm.
    Albanese A; Colosimo C; Carretta D; Dickmann A; Bentivoglio AR; Tonali P
    Eur Neurol; 1992; 32(2):112-7. PubMed ID: 1563461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonographic evaluation of changes in the muscle architecture of the gastrocnemius with botulinum toxin treatment for lower extremity spasticity in children with cerebral palsy.
    Kawano A; Yanagizono T; Kadouchi I; Umezaki T; Chosa E
    J Orthop Sci; 2018 Mar; 23(2):389-393. PubMed ID: 29146092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Future prospects for botulinum toxin therapy].
    Kaji R
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1895-9. PubMed ID: 17037333
    [No Abstract]   [Full Text] [Related]  

  • 12. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type a: once feared, now revered.
    Rohrich RJ; Janis JE
    Plast Reconstr Surg; 2003 Feb; 111(2):867-8. PubMed ID: 12560715
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.
    Alhusaini AA; Crosbie J; Shepherd RB; Dean CM; Scheinberg A
    Dev Med Child Neurol; 2011 Jun; 53(6):553-8. PubMed ID: 21574991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety and efficacy of botulinum toxin in hemifacial spasm].
    Mazlout H; Kamoun Gargouri H; Triki W; Kéfi S; Brour J; El Afrit MA; Chéour M; Kraiem A
    J Fr Ophtalmol; 2013 Mar; 36(3):242-6. PubMed ID: 23270989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin in dermatology].
    Philipp-Dormston WG
    Hautarzt; 2014 Feb; 65(2):133-43; quiz 144-5. PubMed ID: 24549483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of carbamazepine combined with botulinum toxin a in the treatment of blepharospasm and hemifacial spasm.
    Li XH; Lin SC; Hu YF; Liu LY; Liu JB; Hong YC
    Eye Sci; 2012 Dec; 27(4):178-81. PubMed ID: 23225838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications and adverse reactions with the use of botulinum toxin.
    Klein AW
    Dis Mon; 2002 May; 48(5):336-56. PubMed ID: 12195264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Difference of Treatment Results between Botulinum Toxin A Split Injection Sites and Botulinum Toxin A Non-Split Injection Sites for Hemifacial Spasm.
    Prutthipongsit A; Aui-aree N
    J Med Assoc Thai; 2015 Nov; 98(11):1119-23. PubMed ID: 26817183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.